Envision Pharma Group Acquires OKRA.ai

February 8, 2023

Envision Pharma Group, a portfolio company of GHO Capital, has acquired OKRA.ai, an award-winning AI technology provider for the life sciences industry. The add-on expands Envision's technology-enabled capabilities in AI, real-world evidence and data analytics to better support pharmaceutical and biotech clients across the product lifecycle.

Buyers
Envision Pharma Group
Targets
OKRA.ai
Platforms
Envision Pharma Group
Location
United Kingdom
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.